Sign Up Today and Learn More About NeoPhore Stock
Invest in or calculate the value of your shares in NeoPhore or other pre-IPO companies through EquityZen's platform.
NeoPhore Stock (NEOP)
NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.
About NeoPhore Stock
Founded
2017
Industries
Software, Artificial Intelligence, Data and Analytics
NeoPhore Press Mentions
Stay in the know about the latest news on NeoPhore
NeoPhore Closes Series B Extension Round
finsmes • Jun 04, 2024
NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb
prnewswire • May 22, 2024
NeoPhore: Small Molecule Neoantigen Immuno-Oncology Company Raises ÂŁ9.6 Million
pulse2 • Feb 06, 2024
United Kingdom-based Neophore raises GBP 9.5 million in funding
vcbay • Feb 06, 2024
NeoPhore raises an additional ÂŁ9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline
prnewswire • Feb 06, 2024
NeoPhore Management
Leadership team at NeoPhore
Chairman
Robert James
Chief Financial Officer
Stephen Over
Join now and verify your accreditation status to gain access to:
- NeoPhore current valuation
- NeoPhore stock price
- Available deals in NeoPhore and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading NeoPhore Stock
How to invest in NeoPhore stock?
Accredited investors can buy pre-IPO stock in companies like NeoPhore through EquityZen funds. These investments are made available by existing NeoPhore shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell NeoPhore stock?
Shareholders can sell their NeoPhore stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
